Doctorglasses Chain Co.,Ltd.

SZSE:300622 Stock Report

Market Cap: CN¥10.0b

Doctorglasses ChainLtd Future Growth

Future criteria checks 2/6

Doctorglasses ChainLtd is forecast to grow earnings and revenue by 20.5% and 12.3% per annum respectively. EPS is expected to grow by 20.5% per annum. Return on equity is forecast to be 18.8% in 3 years.

Key information

20.5%

Earnings growth rate

20.5%

EPS growth rate

Medical Equipment earnings growth26.1%
Revenue growth rate12.3%
Future return on equity18.8%
Analyst coverage

Low

Last updated01 Dec 2024

Recent future growth updates

No updates

Recent updates

What Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) 32% Share Price Gain Is Not Telling You

Dec 20
What Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) 32% Share Price Gain Is Not Telling You

Here's Why Doctorglasses ChainLtd (SZSE:300622) Can Manage Its Debt Responsibly

Nov 24
Here's Why Doctorglasses ChainLtd (SZSE:300622) Can Manage Its Debt Responsibly

There's Reason For Concern Over Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Massive 25% Price Jump

Nov 05
There's Reason For Concern Over Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Massive 25% Price Jump

Investors Will Want Doctorglasses ChainLtd's (SZSE:300622) Growth In ROCE To Persist

Oct 02
Investors Will Want Doctorglasses ChainLtd's (SZSE:300622) Growth In ROCE To Persist

Some Confidence Is Lacking In Doctorglasses Chain Co.,Ltd. (SZSE:300622) As Shares Slide 27%

Sep 15
Some Confidence Is Lacking In Doctorglasses Chain Co.,Ltd. (SZSE:300622) As Shares Slide 27%

Estimating The Fair Value Of Doctorglasses Chain Co.,Ltd. (SZSE:300622)

Aug 28
Estimating The Fair Value Of Doctorglasses Chain Co.,Ltd. (SZSE:300622)

Investors Appear Satisfied With Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Prospects As Shares Rocket 38%

Jul 30
Investors Appear Satisfied With Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Prospects As Shares Rocket 38%

Solid Earnings Reflect Doctorglasses ChainLtd's (SZSE:300622) Strength As A Business

Apr 09
Solid Earnings Reflect Doctorglasses ChainLtd's (SZSE:300622) Strength As A Business

Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Shares Bounce 28% But Its Business Still Trails The Market

Mar 07
Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Shares Bounce 28% But Its Business Still Trails The Market

Earnings and Revenue Growth Forecasts

SZSE:300622 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,582185N/A2842
12/31/20251,406156N/A1982
12/31/20241,269130N/A2442
9/30/20241,186114230256N/A
6/30/20241,178114224246N/A
3/31/20241,162116228251N/A
12/31/20231,176128259281N/A
9/30/20231,137125285305N/A
6/30/20231,104122261286N/A
3/31/20231,051106239265N/A
1/1/202396276182208N/A
9/30/202295678159192N/A
6/30/202292370154192N/A
3/31/202290680156197N/A
1/1/202288795171214N/A
9/30/2021873108167205N/A
6/30/2021818108166198N/A
3/31/202175896119146N/A
12/31/20206566976102N/A
9/30/2020613486097N/A
6/30/2020607434183N/A
3/31/2020605453987N/A
1/1/2020655624398N/A
9/30/2019631562778N/A
6/30/2019610581463N/A
3/31/201958960449N/A
12/31/201856659-437N/A
9/30/201853759234N/A
6/30/201850857N/A40N/A
3/31/201848755N/A47N/A
12/31/201747152N/A62N/A
9/30/201745749N/A77N/A
6/30/201744042N/A71N/A
3/31/201743141N/A72N/A
12/31/201641638N/A67N/A
3/31/201638737N/A65N/A
12/31/201537635N/A48N/A
12/31/201436134N/A57N/A
12/31/201332833N/A18N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300622's forecast earnings growth (20.5% per year) is above the savings rate (2.8%).

Earnings vs Market: 300622's earnings (20.5% per year) are forecast to grow slower than the CN market (25.7% per year).

High Growth Earnings: 300622's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300622's revenue (12.3% per year) is forecast to grow slower than the CN market (13.7% per year).

High Growth Revenue: 300622's revenue (12.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 300622's Return on Equity is forecast to be low in 3 years time (18.8%).


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 23:57
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Doctorglasses Chain Co.,Ltd. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhong Ping ZhaoChina Merchants Securities Co. Ltd.
Jia Ren LiuIndustrial Securities Co. Ltd.
Wenzheng LiuMinsheng Securities Co.